Schroder Investment Management Group Concert Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$11.25 - $16.17 $408,915 - $587,747	-36,348 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$12.82 - $17.88 $143,635 - $200,327	11,204 Added 44.56%	36,348 $539,000
Q2 2018 Aug 13, 2018	BUY	$16.83 - $21.66 $47,561 - $61,211	2,826 Added 12.66%	25,144 $430,000
Q1 2018 May 11, 2018	BUY	$19.24 - $28.03 $429,398 - $625,573	22,318 New	22,318 $511,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.